A new oral drug has been shown in a large international clinical trial to significantly reduce the relapse rate of people with multiple sclerosis and to slow the progression of the disease.
Oct 6, 2011
0
0
Multiple Sclerosis (MS) is a neurological disease, characterised by demyelination and the onset of chronic, neurodegenerative damage of the central nervous system. Right now, its causes are unknown although various self-immune ...
May 27, 2016
0
123
Around 2.5 million people are affected by the autoimmune disease multiple sclerosis (MS), the most common central nervous system disease among young adults. There are around 12,500 MS sufferers in Austria and 400 new cases ...
Oct 17, 2017
0
7
Using a mouse model of multiple sclerosis (MS), a research team led by UC San Francisco scientists has demonstrated for the first time that regenerating myelin – the fatty insulating sheath surrounding neural fibers that ...
Oct 6, 2016
0
12
Men and women respond differently to diseases and treatments for biological, social and psychological reasons. In this series on Gender Medicine, experts explore these differences and the importance of approaching treatment ...
Aug 7, 2017
2
161
University of Malta researchers have discovered a potential cause of the persistent and often debilitating symptoms experienced by long COVID-19 patients. The new study published in Biochimica et Biophysica Acta (BBA)—Molecular ...
Aug 16, 2023
0
18
The culmination of three decades of research in Cambridge has resulted in the exciting prospect of a new transformational treatment for multiple sclerosis.
Nov 15, 2011
0
0
A rare and powerful type of immune cell has been discovered in the meninges around the brain, suggesting the cells may play a critical but previously unappreciated role in battling Alzheimer's, multiple sclerosis, meningitis ...
Dec 19, 2016
0
35
Researchers from the Saint Louis University School of Medicine have discovered why many multiple myeloma patients experience severe pain when treated with the anticancer drug bortezomib. The study, which will be published ...
Apr 27, 2018
0
133
The first study to investigate risk factors for the vascular condition called CCSVI (chronic cerebrospinal venous insufficiency) in volunteers without neurological disease has identified what the researchers call a remarkable ...
Nov 30, 2011
0
0
